177 related articles for article (PubMed ID: 21900026)
1. Enhancement of antibacterial activity of tilmicosin against Staphylococcus aureus by solid lipid nanoparticles in vitro and in vivo.
Wang XF; Zhang SL; Zhu LY; Xie SY; Dong Z; Wang Y; Zhou WZ
Vet J; 2012 Jan; 191(1):115-20. PubMed ID: 21900026
[TBL] [Abstract][Full Text] [Related]
2. Preparation, characterization, and pharmacokinetics of tilmicosin- and florfenicol-loaded hydrogenated castor oil-solid lipid nanoparticles.
Ling Z; Yonghong L; Changqing S; Junfeng L; Li Z; Chunyu J; Xianqiang L
J Vet Pharmacol Ther; 2017 Jun; 40(3):293-303. PubMed ID: 27687707
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the antibacterial activity of tilmicosin-SLN against
Zhu L; Cao X; Xu Q; Su J; Li X; Zhou W
Int J Nanomedicine; 2018; 13():4747-4755. PubMed ID: 30147316
[TBL] [Abstract][Full Text] [Related]
4. Hydrogenated castor oil nanoparticles as carriers for the subcutaneous administration of tilmicosin: in vitro and in vivo studies.
Han C; Qi CM; Zhao BK; Cao J; Xie SY; Wang SL; Zhou WZ
J Vet Pharmacol Ther; 2009 Apr; 32(2):116-23. PubMed ID: 19290940
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of intramammary tilmicosin and risk factors for cure of Staphylococcus aureus infection in the dry period.
Dingwell RT; Leslie KE; Duffield TF; Schukken YH; DesCoteaux L; Keefe GP; Kelton DF; Lissemore KD; Shewfelt W; Dick P; Bagg R
J Dairy Sci; 2003 Jan; 86(1):159-68. PubMed ID: 12613861
[TBL] [Abstract][Full Text] [Related]
6. Comparison of tilmicosin and cephapirin as therapeutics for Staphylococcus aureus mastitis at dry-off.
Nickerson SC; Owens WE; Fox LK; Scheifinger CC; Shryock TR; Spike TE
J Dairy Sci; 1999 Apr; 82(4):696-703. PubMed ID: 10212455
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of parenterally or intramammarily administered tilmicosin or ceftiofur against Staphylococcus aureus mastitis during lactation.
Owens WE; Nickerson SC; Ray CH
J Dairy Sci; 1999 Mar; 82(3):645-7. PubMed ID: 10194686
[TBL] [Abstract][Full Text] [Related]
8. Enhanced antibacterial activity of tilmicosin against
Luo W; Liu J; Zhang S; Song W; Algharib SA; Chen W
J Vet Sci; 2022 Jan; 23(1):e1. PubMed ID: 34931502
[TBL] [Abstract][Full Text] [Related]
9. Formulation, characterization and pharmacokinetics of praziquantel-loaded hydrogenated castor oil solid lipid nanoparticles.
Xie S; Pan B; Wang M; Zhu L; Wang F; Dong Z; Wang X; Zhou W
Nanomedicine (Lond); 2010 Jul; 5(5):693-701. PubMed ID: 20662641
[TBL] [Abstract][Full Text] [Related]
10. Acute toxicity study of tilmicosin-loaded hydrogenated castor oil-solid lipid nanoparticles.
Xie S; Wang F; Wang Y; Zhu L; Dong Z; Wang X; Li X; Zhou W
Part Fibre Toxicol; 2011 Nov; 8():33. PubMed ID: 22098626
[TBL] [Abstract][Full Text] [Related]
11. Tilmicosin modulates the innate immune response and preserves casein production in bovine mammary alveolar cells during Staphylococcus aureus infection.
Martínez-Cortés I; Acevedo-Domínguez NA; Olguin-Alor R; Cortés-Hernández A; Álvarez-Jiménez V; Campillo-Navarro M; Sumano-López HS; Gutiérrez-Olvera L; Martínez-Gómez D; Maravillas-Montero JL; Loor JJ; García-Zepeda EA; Soldevila G
J Anim Sci; 2019 Feb; 97(2):644-656. PubMed ID: 30517644
[TBL] [Abstract][Full Text] [Related]
12. Preparation and in vitro, in vivo evaluations of norfloxacin-loaded solid lipid nanopartices for oral delivery.
Dong Z; Xie S; Zhu L; Wang Y; Wang X; Zhou W
Drug Deliv; 2011 Aug; 18(6):441-50. PubMed ID: 21554156
[TBL] [Abstract][Full Text] [Related]
13. Tilmicosin- and florfenicol-loaded hydrogenated castor oil-solid lipid nanoparticles to pigs: Combined antibacterial activities and pharmacokinetics.
Ling Z; Yonghong L; Junfeng L; Li Z; Xianqiang L
J Vet Pharmacol Ther; 2018 Apr; 41(2):307-313. PubMed ID: 29139136
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial activity of thionin Thi2.1 from Arabidopsis thaliana expressed by bovine endothelial cells against Staphylococcus aureus isolates from bovine mastitis.
Ochoa-Zarzosa A; Loeza-Angeles H; Sagrero-Cisneros E; Villagómez-Gómez E; Lara-Zárate L; López-Meza JE
Vet Microbiol; 2008 Mar; 127(3-4):425-30. PubMed ID: 17961938
[TBL] [Abstract][Full Text] [Related]
15. Concentrations of tilmicosin in mammary gland secretions of dairy cows following subcutaneous administration of one or two doses of an experimental preparation of tilmicosin and its efficacy against intramammary infections caused by Staphylococcus aureus.
Mendoza J; Martínez-Cortés I; López-Ordaz R; Gutiérrez L; Sumano H
Am J Vet Res; 2016 Sep; 77(9):922-30. PubMed ID: 27580103
[TBL] [Abstract][Full Text] [Related]
16. The controlled release of tilmicosin from silica nanoparticles.
Song M; Li Y; Fai C; Cui S; Cui B
Drug Dev Ind Pharm; 2011 Jun; 37(6):714-8. PubMed ID: 21204738
[TBL] [Abstract][Full Text] [Related]
17. Mouse mastitis model of infection for antimicrobial compound efficacy studies against intracellular and extracellular forms of Staphylococcus aureus.
Brouillette E; Grondin G; Lefebvre C; Talbot BG; Malouin F
Vet Microbiol; 2004 Aug; 101(4):253-62. PubMed ID: 15261998
[TBL] [Abstract][Full Text] [Related]
18. Enhancement in antifungal activity of eugenol in immunosuppressed rats through lipid nanocarriers.
Garg A; Singh S
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):280-8. PubMed ID: 21689909
[TBL] [Abstract][Full Text] [Related]
19. In vitro antimicrobial effect and in vivo preventive and therapeutic effects of partially purified lantibiotic lacticin NK34 against infection by Staphylococcus species isolated from bovine mastitis.
Kim SY; Shin S; Koo HC; Youn JH; Paik HD; Park YH
J Dairy Sci; 2010 Aug; 93(8):3610-5. PubMed ID: 20655430
[TBL] [Abstract][Full Text] [Related]
20. Preparation and evaluation of tilmicosin-loaded hydrogenated castor oil nanoparticle suspensions of different particle sizes.
Chen X; Wang T; Lu M; Zhu L; Wang Y; Zhou W
Int J Nanomedicine; 2014; 9():2655-64. PubMed ID: 24920902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
